Inflammation in CNS neurodegenerative diseases J Stephenson, E Nutma, P van der Valk, S Amor Immunology 154 (2), 204-219, 2018 | 819 | 2018 |
Astrocyte and oligodendrocyte cross-talk in the central nervous system E Nutma, D van Gent, S Amor, LAN Peferoen Cells 9 (3), 600, 2020 | 122 | 2020 |
Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders J Bryois, D Calini, W Macnair, L Foo, E Urich, W Ortmann, VA Iglesias, ... Nature neuroscience 25 (8), 1104-1112, 2022 | 114 | 2022 |
Cellular sources of TSPO expression in healthy and diseased brain E Nutma, K Ceyzériat, S Amor, S Tsartsalis, P Millet, DR Owen, ... European journal of nuclear medicine and molecular imaging, 1-18, 2021 | 112 | 2021 |
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation R Berglund, AO Guerreiro-Cacais, MZ Adzemovic, M Zeitelhofer, H Lund, ... Science immunology 5 (52), eabb5077, 2020 | 103 | 2020 |
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis E Nutma, JA Stephenson, RP Gorter, J de Bruin, DM Boucherie, CK Donat, ... Brain 142 (11), 3440-3455, 2019 | 98 | 2019 |
Neuroimmunology–the past, present and future E Nutma, H Willison, G Martino, S Amor Clinical & Experimental Immunology 197 (3), 278-293, 2019 | 71 | 2019 |
Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain E Nutma, E Gebro, MC Marzin, P van der Valk, PM Matthews, DR Owen, ... Glia 69 (10), 2447-2458, 2021 | 60 | 2021 |
White matter microglia heterogeneity in the CNS S Amor, NB McNamara, E Gerrits, MC Marzin, SM Kooistra, VE Miron, ... Acta Neuropathologica 143 (2), 125-141, 2022 | 54 | 2022 |
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases E Nutma, N Fancy, M Weinert, S Tsartsalis, MC Marzin, RCJ Muirhead, ... Nature communications 14 (1), 5247, 2023 | 47 | 2023 |
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia E Vankriekelsvenne, U Chrzanowski, K Manzhula, T Greiner, A Wree, ... Glia 70 (6), 1170-1190, 2022 | 39 | 2022 |
Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter A Miedema, E Gerrits, N Brouwer, Q Jiang, L Kracht, M Meijer, E Nutma, ... Acta neuropathologica communications 10 (1), 8, 2022 | 33 | 2022 |
Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes RP Gorter, J Stephenson, E Nutma, J Anink, JC de Jonge, W Baron, ... Neuropathology and applied neurobiology 45 (5), 459-475, 2019 | 26 | 2019 |
Synaptic loss in multiple sclerosis spinal cord N Petrova, E Nutma, D Carassiti, J RS Newman, S Amor, DR Altmann, ... Annals of neurology 88 (3), 619-625, 2020 | 24 | 2020 |
Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis RP Gorter, E Nutma, MC Jahrei, JC de Jonge, RA Quinlan, P van der Valk, ... Clinical & Experimental Immunology 194 (2), 137-152, 2018 | 18 | 2018 |
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model D Baker, E Nutma, H O'Shea, A Cooke, JM Orian, S Amor Annals of Clinical and Translational Neurology 6 (8), 1362-1372, 2019 | 17 | 2019 |
Myeloid cell‐specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation K Zhu, Y Wang, H Sarlus, K Geng, E Nutma, J Sun, SY Kung, C Bay, ... EMBO reports 23 (7), e54499, 2022 | 15 | 2022 |
Single nuclei RNAseq stratifies multiple sclerosis patients into distinct white matter glial responses W Macnair, D Calini, E Agirre, J Bryois, S Jäkel, P Kukanja, N Stokar, V Ott, ... BioRxiv, 2022.04. 06.487263, 2022 | 12 | 2022 |
Autophagy in white matter disorders of the CNS: Mechanisms and therapeutic opportunities E Nutma, MC Marzin, SAGM Cillessen, S Amor The Journal of Pathology 253 (2), 133-147, 2021 | 10 | 2021 |
Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro C Bridel, MJA Koel‐Simmelink, L Peferoen, C Derada Troletti, S Durieux, ... Neuropathology and applied neurobiology 44 (4), 404-416, 2018 | 10 | 2018 |